Trump tariffs could raise medication costs and exacerbate shortages, drug trade groups warn
President Donald Trump's steep tariffs on Canada, Mexico and China could worsen existing drug shortages in the U.S. and raise healthcare costs for patients, some drug trade groups warn. They also said the import taxes could strain cash-strapped generic drugmakers and distributors.